Effects of chronic tramadol exposure on the zebrafish brain: A proteomic study

Journal of Proteomics

Volumn 75, Issue 11, 2012, Pages 3351-3364

  Zhuo, Hui Qin ^a,b   Huang, Lin ^c   Huang, He Qing ^a,b   Cai, Zongwei ^d  

^a XIAMEN UNIVERSITY   (China)

^b ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

^c OREGON STATE UNIVERSITY   (United States)

^d HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Abuse potential; Metabolism; Oxidative stress; Proteomics; Tramadol hydrochloride

Indexed keywords

ACTIN; CREATINE KINASE; CREATINE KINASE BB; N DESMETHYLTRAMADOL; O NORTRAMADOL; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TRAMADOL; TUBULIN; UBIQUITIN CARBOXY TERMINAL HYDROLASE L 1; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG;

ABNORMAL BEHAVIOR; APOPTOSIS; ARTICLE; BODY WEIGHT; BRAIN; BRAIN TISSUE; ENERGY METABOLISM; METABOLITE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEOMICS; SYNAPTOSOME; WEIGHT REDUCTION; ZEBRA FISH;

ANALGESICS, OPIOID; ANIMALS; BRAIN; BRAIN CHEMISTRY; MITOCHONDRIA; NERVE TISSUE PROTEINS; PROTEOMICS; TRAMADOL; ZEBRAFISH;

DANIO RERIO;

EID: 84861664137     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.03.038     Document Type: Article

References (68)

1. Grond S., Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet 2004, 43:879-923.
2. Brattwall M., Turan I., Jakobsson J. Musculoskeletal pain: prescription of NSAD and weak opioid by primary health care physicians in Sweden 2004-2008-a retrospective patient record review. J Pain Res 2010, 3:131-135.
3. Saccomanni G., Del Carlo S., Giorgi M., Manera C., Saba A., Macchia M. Determination of tramadol and metabolites by HPLC-FL and HPLC-MS/MS in urine of dogs. J Pharm Biomed Anal 2010, 53:194-199.
4. Souza M.J., Martin-Jimenez T., Jones M.P., Cox S.K. Pharmacokinetics of oral tramadol in red-tailed hawks (Buteo jamaicensis). J Vet Pharmacol Ther 2011, 34:86-88.
5. Ogata J., Minami K., Uezono Y., Okamoto T., Shiraishi M., Shiqematsu A., et al. The inhibitory effects of tramadol on 5-hydroxytryptamine type 2C receptors expressed in Xenopus oocytes. Anesth Analg 2004, 98:1401-1406.
6. Tsai T.Y., Tsai Y.C., Wu S.N., Liu Y.C. Tramadol-induced blockade of delayed rectifier potassium current in NG108-15 neuronal cells. Eur J Pain 2006, 10:597-601.
7. + channels in rat aorta. Can J Anaesth 2007, 54:453-460.
8. Clarkson J.E., Lacy J.M., Fligner C.L., Thiersch N., Howard J., Harruff R.C., et al. Tramadol (Ultram) concentrations in death investigation and impaired driving cases and their significance. J Forensic Sci 2004, 49:1101-1105.
9. Tjäderborn M., Jönsson A.K., Hägg S., Ahlner J. Fatal unintentional intoxications with tramadol during 1995-2005. Forensic Sci Int 2007, 173:107-111.
10. Epstein D.H., Preston K.L., Jasinski D.R. Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol. Biol Psychol 2006, 73:90-99.
11. Kim S.Y., Chudapongse N., Lee S.M., Levin M.C., Oh J.T., Park H.J., et al. Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains. Brain Res Mol Brain Res 2005, 133:58-70.
12. Bierczynska-Krzysik A., Bonar E., Drabik A., Noga M., Suder P., Dylag T., et al. Rat brain proteome in morphine dependence. Neurochem Int 2006, 49:401-406.
13. Bierczynska-Krzysik A., Pradeep John J.P., Silberring J., Kotlinska J., Dylag T., Cabatic M., et al. Proteomic analysis of rat cerebral cortex, hippocampus and striatum after exposure to morphine. Int J Mol Med 2006, 18:775-784.
14. Yang L., Sun Z.S., Zhu Y.P. Proteomic analysis of rat prefrontal cortex in three phases of morphine-induced conditioned place preference. J Proteome Res 2007, 6:2239-2247.
15. Li Q., Zhao X., Zhong L.J., Yang H.Y., Wang Q., Pu X.P. Effects of chronic morphine treatment on protein expression in rat dorsal root ganglia. Eur J Pharmacol 2009, 612:21-28.
16. Reynolds J.L., Mahajan S.D., Bindukumar B., Sykes D., Schwartz S.A., Nair M.P. Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res 2006, 1123:226-236.
17. Jeon J.P., Buono R.J., Han B.G., Jang E.Y., Kim S.C., Yang C.H., et al. Proteomic and behavioral analysis of response to isoliquiritigenin in brains of acute cocaine treated rats. J Proteome Res 2008, 7:5094-5102.
18. Del Castillo C., Morales L., Alguacil L.F., Salas E., Garrido E., Pérez-García C. Proteomic analysis of the nucleus accumbens of rats with different vulnerability to cocaine addiction. Neuropharmacology 2009, 57:41-48.
19. Yeom M., Shim I., Lee H.J., Hahm D.H. Proteomic analysis of nicotine-associated protein expression in the striatum of repeated nicotine-treated rats. Biochem Biophys Res Commun 2005, 326:321-328.
20. Piubelli C., Cecconi D., Astner H., Caldara F., Tessari M., Carboni L., et al. Proteomic changes in rat serum, polymorphonuclear and mononuclear leukocytes after chronic nicotine administration. Proteomics 2005, 5:1382-1394.
21. Reynolds J.L., Mahajan S.D., Sykes D., Nair M.P. Heroin-induces differential protein expression by normal human astrocytes (NHA). Am J Infect Dis 2006, 2:49-57.
22. Kashem M.A., James G., Harper C., Wilce P., Matsumoto I. Differential protein expression in the corpus callosum (splenium) of human alcoholics: a proteomics study. Neurochem Int 2007, 50:450-459.
23. Kashem M.A., Harper C. Differential protein expression in the corpus callosum (genu) of human alcoholics. Neurochem Int 2008, 53:1-11.
24. Kim S.Y., Chudapongse N., Lee S.M., Levin M.C. Proteomic analysis of phosphotyrosyl proteins in the rat brain: effect of butorphanol dependence. J Neurosci Res 2004, 77:867-877.
25. Cunha-Oliveira T., Rego A.C., Oliveira C.R. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Brain Res Rev 2008, 58:192-208.
26. Irons T.D., MacPhail R.C., Hunter D.L., Padilla S. Acute neuroactive drug exposures alter locomotor activity in larval zebrafish. Neurotoxicol Teratol 2010, 32:84-90.
27. Ali S., Champagne D.L., Alia A., Richardson M.K. Large-scale analysis of acute ethanol exposure in zebrafish development: a critical time window and resilience. PLoS One 2011, 6:e20037.
28. Gebauer D.L., Pagnussat N., Piato A.L., Schaefer I.C., Bonan C.D., Lara D.R. Effects of anxiolytics in zebrafish: similarities and differences between benzodiazepines, buspirone and ethanol. Pharmacol Biochem Behav 2011, 99:480-486.
29. Sanchez-Simon F.M., Arenzana F.J., Rodriguez R.Z. In vivo effects of morphine on neuronal fate and opioid receptor expression in zebrafish embryos. Eur J Neurosci 2010, 32:550-559.
30. Westerfield M. The Zebrafish Book. A Guide for the Laboratory Use of zebrafish (Danio rerio) 2000, Univ. of Oregon Press, Eugene. 4th ed.
31. Leis H.J., Fauler G., Windischhofer W. Synthesis of d1-N-ethyltramadol as an internal standard for the quantitative determination of tramadol in human plasma by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 804:369-374.
32. Bodzon-Kulakowska A., Suder P., Mark P., Bierczynska-Kizysik A., Lubec G., Walczak B., et al. Proteomic analysis of striatal neuronal cell cultures after morphine administration. J Sep Sci 2009, 32:1200-1210.
33. Zimmerman L.J., Wernke G.R., Caprioli R.M., Liebler D.C. Identification of protein fragments as pattern features in MALDI-MS analysis of serum. J Proteome Res 2005, 4:1672-1680.
34. Gonzalez-Nuñez V., Marrón Fernández de Velasco E., Arsequell G., Valencia G., Rodríguez R.E. Identification of dynorphin A from zebrafish: a comparative study with mammalian dynorphin A. Neuroscience 2007, 144:675-684.
35. Sanchez-Simon F.M., Rodriguez R.E. Developmental expression and distribution of opioid receptors in zebrafish. Neuroscience 2008, 151:129-137.
36. Nickel B., Aledter A. Comparative physical dependence studies in rats with flupirtine and opiate receptor stimulating analgesics. Postgrad Med J 1987, 63:41-43.
37. Giorgi M., Soldani G., Manera C., Ferrarini P.L., Sgorbini M., Saccomanni G. Pharmacokinetics of tramadol and its metabolites M1, M2 and M5 in horses following intravenous, immediate release (fasted/fed) and sustained release single dose administration. J Equine Vet Sci 2007, 27:481-488.
38. Giorgi M., Carlo S.D., Sgorbini M., Saccomanni G. Pharmacokinetics of tramadol and its metabolites M1, M2, and M5 in donkeys after intravenous and oral immediate release single-dose administration. J Equine Vet Sci 2009, 29:569-574.
39. Vettorato E., Zonca A., Isola M., Villa R., Gallo M., Ravasio G., et al. Pharmacokinetics and efficacy of intravenous and extradural tramadol in dogs. Vet J 2010, 183:310-315.
40. Feng S., Xu Z., Yan Y.B. Blocking creatine kinase refolding by trace amounts of copper ions. J Inorg Biochem 2008, 102:928-935.
41. Streck E.L., Amboni G., Scaini G., Di-Pietro P.B., Rezin G.T., Valvassori S.S., et al. Brain creatine kinase activity in an animal model of mania. Life Sci 2008, 82:424-429.
42. Setsuie R., Wada K. The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem Int 2007, 51:105-111.
43. Gong B., Cao Z., Zheng P., Vitolo O.V., Liu S., Staniszewski A., et al. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 2006, 126:775-788.
44. Dubois T., Rommel C., Howell S., Steinhussen U., Soneji Y., Morrice N., et al. 14-3-3 is phosphorylated by casein kinase I on residue 233. Phosphorylation at this site in vivo regulates Raf/14-3-3 interaction. J Biol Chem 1997, 272:28882-28888.
45. Bunney T.D., van Walraven H.S., de Boer A.H. 14-3-3 protein is a regulator of the mitochondrial and chloroplast ATP synthase. Proc Natl Acad Sci U S A 2001, 98:4249-4254.
46. Schoonheim P.J., Veiga H., Pereira Dda C., Friso G., van Wijk K.J., de Boer A.H. A comprehensive analysis of the 14-3-3 interactome in barley leaves using a complementary proteomics and two-hybrid approach. Plant Physiol 2007, 143:670-683.
47. Alexander R.D., Morris P.C. A proteomic analysis of 14-3-3 binding proteins from developing barley grains. Proteomics 2006, 6:1886-1896.
48. Pozuelo Rubio M., Geraghty K.M., Wong B.H., Wood N.T., Campbell D.G., Morrice N., et al. 14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochem J 2004, 379:395-408.
49. Luk S.C., Ngai S.M., Tsui S.K., Fung K.P., Lee C.Y., Waye M.M. In vivo and in vitro association of 14-3-3 epsilon isoform with calmodulin: implication for signal transduction and cell proliferation. J Cell Biochem 1999, 73:31-35.
50. Butterfield D.A., Reed T., Newman S.F., Sultana R. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 2007, 43:658-677.
51. Butterfield D.A., Castegna A., Lauderback C.M., Drake J. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 2002, 23:655-664.
52. Hwang Y.Y., Li M.D. Proteins differentially expressed in response to nicotine in five rat brain regions: identification using a 2-DE/MS-based proteomics approach. Proteomics 2006, 6:3138-3153.
53. Li M.D., Wang J. Neuroproteomics and its applications in research on nicotine and other drugs of abuse. Proteomics Clin Appl 2007, 1:1406-1427.
54. Park B., Jeong S.K., Lee W.S., Seong J.K., Paik Y.K. A simple pattern classification method for alcohol-responsive proteins that are differentially expressed in mouse brain. Proteomics 2004, 4:3369-3375.
55. Bell R.L., Kimpel M.W., Rodd Z.A., Strother W.N., Bai F., Peper C.L., et al. Protein expression changes in the nucleus accumbens and amygdala of inbred alcohol-preferring rats given either continuous or scheduled access to ethanol. Alcohol 2006, 40:3-17.
56. Alexander-Kaufman K., James G., Sheedy D., Harper C., Matsumoto I. Differential protein expression in the prefrontal white matter of human alcoholics: a proteomics study. Mol Psychiatry 2006, 11:56-65.
57. Freeman W.M., Brebner K., Amara S.G., Reed M.S., Pohl J., Phillips A.G. Distinct proteomic profiles of amphetamine self-administration transitional states. Pharmacogenomics J 2005, 5:203-214.
58. Li K.W., Jimenez C.R., van der Schors R.C., Hornshaw M.P., Schoffelmeer A.N., Smit A.B. Intermittent administration of morphine alters protein expression in rat nucleus accumbens. Proteomics 2006, 6:2003-2008.
59. Tannu N., Mash D.C., Hemby S.E. Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims. Mol Psychiatry 2007, 12:55-73.
60. Lewohl J.M., Van Dyk D.D., Craft G.E., Innes D.J., Mayfield R.D., Cobon G., et al. The application of proteomics to the human alcoholic brain. Ann N Y Acad Sci 2004, 1025:14-26.
61. Iwazaki T., McGregor I.S., Matsumoto I. Protein expression profile in the striatum of acute methamphetamine treated rats. Brain Res 2006, 1097:19-25.
62. Prokai L., Zharikova A.D., Stevens S.M. Effect of chronic morphine exposure on the synaptic plasma-membrane subproteome of rats: a quantitative protein profiling study based on isotope-coded affinity tags and liquid chromatography/mass spectrometry. J Mass Spectrom 2005, 40:169-175.
63. Moron J.A., Abul-Husn N.S., Rozenfeld R., Dolios G., Wang R., Devi L.A. Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins: a proteomics study focusing on endocytic proteins. Mol Cell Proteomics 2007, 6:29-42.
64. Singh S.K., Rakesh K.S., Ramamoorthy K., Saradhi A.V.P., Idris M.M. Proteome profile of zebrafish brain based on gel LC-ESI MS/MS analysis. J Proteomics Bioinform 2010, 3:135-142.
65. Huang Q.Y., Huang H.Q. Differential expression profile of membrane proteins in zebrafish (Danio rerio) brain exposed to methyl parathion. Proteomics 2011, 11:3743-3756.
66. Biales A.D., Bencic D.C., Villeneuve D.L., Ankley G.T., Lattier D.L. Proteomic analysis of zebrafish brain tissue following exposure to the pesticide prochloraz. Aquat Toxicol 2011, 105:618-628.
67. Cheng J.T., Liu I.M., Chi T.C., Tzeng T.F., Lu F.H., Chang C.J. Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes 2001, 50:2815-2821.
68. Choi S.B., Jang J.S., Park S. Tramadol enhances hepatic insulin sensitivity via enhancing insulin signaling cascade in the cerebral cortex and hypothalamus of 90% pancreatectomized rats. Brain Res Bull 2005, 67:77-86.